Aussies & Kiwis with incurable blood cancer receive newly subsidised treatment option

By VIVA! Communications | April 1, 2020

Today, VIVA! partnered with Celgene, a Bristol-Myers Squibb company, Multiple Myeloma Australia and Multiple Myeloma New Zealand to announce a newly reimbursed treatment option for Australians and New Zealanders living with incurable blood cancer, multiple myeloma. REVLIMID® (lenalidomide) – the first and only maintenance treatment in ANZ specifically indicated and reimbursed for those with newly…

Read More

Communicating with personnel during the COVID-19 pandemic

By VIVA! Communications | March 30, 2020

Our own VIVA! Communications Principal and owner, Kirsten Bruce, Sydney was quoted in pharmaceutical industry publication, Pharma in Focus today on how to engage with staff working from home during the current COVID-19 pandemic. She cited the importance of corporate messaging being “clear, concise and reassuring to their employees, customers and stakeholders alike, explaining that…

Read More

1 in 10 Aussies with epilepsy sustaining serious physical injuries

By VIVA! Communications | March 26, 2020

VIVA! Communications is delighted to be teaming with UCB today (Thursday, March 26, 2020) to highlight the serious injuries caused by epileptic seizures, and call for heightened awareness, understanding and support for the 250,000 Australians living with epilepsy. One in 10 Australians living with epilepsy experience a seizure-related injury each year, many of which are…

Read More

COVID-19 (coronavirus) – Q&A with VIVA! Principal & owner, Kirsten Bruce

By VIVA! Communications | March 11, 2020

In the wake of Australia’s #toiletpapergate following widespread #coronavirus #panicbuying, VIVA! Communications’ Agency Principal and owner, Kirsten Bruce, is discussing the role of responsible health communications in stemming public panic in the face of a pandemic: Q: How well is this crisis is being handled from both a government and brand communications perspective? A: The…

Read More